The new device could help researchers see how different types of tissue respond to drugs without using lab animals.
Back story: Current organ-on-a chip systems place different kinds of human cells into a device andthen push fluid through them to mimic blood flow. That lets researchers see how, say, lung cells respond to different conditions.
What’s new: MIT engineers have now built a more complex version, which combines cells from 10 different organs—liver, lung, gut, endometrium, brain, heart, pancreas, kidney, skin, and skeletal muscle. That allows tests to see how different model organs react and interact with each other when exposed to different chemicals in the fluid.
Why it matters: The cells can live for up to four weeks of testing, and the team has already used the setup to see how the different model organs respond to painkillers. It’s still a crude approximation of our body, but it could be used to test how organs react to early-stage drugs.
These scientists used CRISPR to put an alligator gene into catfish
The resulting fish appear to be more resistant to disease and could improve commercial production—should they ever be approved.
Next up for CRISPR: Gene editing for the masses?
Last year, Verve Therapeutics started the first human trial of a CRISPR treatment that could benefit most people—a signal that gene editing may be ready to go mainstream.
CRISPR for high cholesterol: 10 Breakthrough Technologies 2023
New forms of the gene-editing tool could enable treatments for common diseases.
An ALS patient set a record for communicating via a brain implant: 62 words per minute
Brain interfaces could let paralyzed people speak at almost normal speeds.
Get the latest updates from
MIT Technology Review
Discover special offers, top stories, upcoming events, and more.